Page last updated: 2024-09-05

zm 241385 and iberiotoxin

zm 241385 has been researched along with iberiotoxin in 2 studies

Compound Research Comparison

Studies
(zm 241385)
Trials
(zm 241385)
Recent Studies (post-2010)
(zm 241385)
Studies
(iberiotoxin)
Trials
(iberiotoxin)
Recent Studies (post-2010) (iberiotoxin)
40131247770150

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hein, TW; Kuo, L; Muthuchamy, M; Wang, W; Zoghi, B1
Marshall, JM; Ray, CJ1

Other Studies

2 other study(ies) available for zm 241385 and iberiotoxin

ArticleYear
Functional and molecular characterization of receptor subtypes mediating coronary microvascular dilation to adenosine.
    Journal of molecular and cellular cardiology, 2001, Volume: 33, Issue:2

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenosine; Animals; Antihypertensive Agents; Blotting, Western; Colforsin; Coronary Vessels; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Female; Glyburide; Heart; Hypoglycemic Agents; In Situ Hybridization; Male; Microcirculation; Myocardium; Peptides; Phenethylamines; Potassium Channel Blockers; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Reverse Transcriptase Polymerase Chain Reaction; Stress, Physiological; Swine; Thionucleotides; Tissue Distribution; Triazines; Triazoles

2001
The cellular mechanisms by which adenosine evokes release of nitric oxide from rat aortic endothelium.
    The Journal of physiology, 2006, Jan-01, Volume: 570, Issue:Pt 1

    Topics: Adenosine; Animals; Aorta, Thoracic; Apamin; Arachidonic Acids; Calcium; Endothelium, Vascular; In Vitro Techniques; Large-Conductance Calcium-Activated Potassium Channels; Male; Nitric Oxide; Peptides; Phospholipases A; Phospholipases A2; Rats; Rats, Wistar; Receptor, Adenosine A1; Receptors, Adenosine A2; Second Messenger Systems; Small-Conductance Calcium-Activated Potassium Channels; Triazines; Triazoles; Vasodilator Agents; Xanthines

2006